Old Web
English
Sign In
Acemap
>
authorDetail
>
Krystallia Gourlia
Krystallia Gourlia
University of Crete
non small cell
Medicine
Oncology
Internal medicine
immune checkpoint inhibitors
4
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non- Small Cell Lung Cancer
2021
Sofia Agelaki
Krystallia Gourlia
Maria Markaki
Chara Papadaki
Konstantinos Rounis
Eleftherios Vorrias
Elena Prokova
Eleni Lagoudaki
Anastasios Koutsopoulos
Ioannis Tsamardinos
Dimitrios Mavroudis
Show All
Source
Cite
Save
Citations (0)
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
2021
PLOS ONE
Konstantinos Rounis
Dimitrios Makrakis
Chara Papadaki
Alexia Monastirioti
Lambros Vamvakas
Konstantinos Kalbakis
Krystallia Gourlia
Iordanis Xanthopoulos
Ioannis Tsamardinos
Dimitrios Mavroudis
Sofia Agelaki
Show All
Source
Cite
Save
Citations (1)
Accurate Blood-Based Diagnostic Biosignatures for Alzheimer's Disease via Automated Machine Learning.
2020
Journal of Clinical Medicine
Makrina Karaglani
Krystallia Gourlia
Ioannis Tsamardinos
Ekaterini Chatzaki
Show All
Source
Cite
Save
Citations (5)
Intergration of common clinical and laboratory parameters for predictive modeling of outcome with immune checkpoint inhibitors (ICIs) in patients (pts) with Nnon-small cell lung cancer (NSCLC).
2020
Journal of Clinical Oncology
Konstantinos Rounis
Dimitrios Makrakis
Chara Papadaki
Alexia Monastirioti
Lampros Vamvakas
Kostas Kalbakis
Krystallia Gourlia
Iordanis Xanthopoulos
Dimitrios Mavroudis
Sofia Agelaki
Show All
Source
Cite
Save
Citations (0)
1